Results
Latest quarterly results
Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.
SectorAll 3892Healthcare 878Financial Services 629Technology 560Industrials 517Consumer Cyclical 330Basic Materials 232Energy 196Communication Services 168Real Estate 161Consumer Defensive 134Utilities 87
| Company | Sector | Reported | Quarter | Revenue | Rev. YoY | Net income | NI YoY | EPS | EPS YoY | Op. margin | Margin chg. | Market cap |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NXTCNextCure, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$7.0M | n/m | −$1.29 | n/m | — | — | $31M |
| ABVCABVC BioPharma, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | $1.0M | n/m | $0.04 | n/m | — | — | $25M |
| QTIQT Imaging Holdings, Inc. | Healthcare | Nov 10 | Sep '26 | $7.0M | +75.0% | $0.0M | n/m | −$0.02 | n/m | -33.4% | +6.1 pp | $25M |
| MGXMetagenomi Therapeutics, Inc. | Healthcare | Nov 10 | Sep '26 | $2.0M | −77.8% | −$21.0M | n/m | −$0.56 | n/m | — | — | $24M |
| LITSLite Strategy, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | $16.0M | n/m | $0.48 | n/m | — | — | $24M |
| ATOSAtossa Therapeutics, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$6.0M | n/m | −$0.56 | n/m | — | — | $19M |
| CNTXContext Therapeutics Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$8.0M | n/m | −$0.08 | n/m | — | — | $16M |
| SNWVSANUWAVE Health, Inc. | Healthcare | Nov 10 | Sep '26 | $9.0M | −18.2% | −$1.0M | −110.0% | −$0.16 | −114.2% | -12.5% | −25.3 pp | $15M |
| PASGPassage Bio, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$5.0M | n/m | −$1.47 | n/m | — | — | $14M |
| BNGOBionano Genomics, Inc. | Healthcare | Nov 10 | Sep '26 | $8.0M | +14.3% | −$6.0M | n/m | −$0.54 | n/m | -79.0% | +36.9 pp | $13M |
| CLRBCellectar Biosciences, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$8.0M | n/m | −$0.46 | n/m | — | — | $9M |
| INBSIntelligent Bio Solutions Inc. | Healthcare | Nov 10 | Sep '26 | $1.0M | 0.0% | −$3.0M | n/m | −$0.86 | n/m | -192.8% | +70.9 pp | $5M |
| SNOASonoma Pharmaceuticals, Inc. | Healthcare | Nov 10 | Sep '26 | $7.0M | +16.7% | $0.0M | n/m | −$0.01 | n/m | 4.0% | +10.1 pp | $4M |
| CALCCalciMedica, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$2.0M | n/m | −$0.24 | n/m | — | — | $4M |
| DRMADermata Therapeutics, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$3.0M | n/m | −$0.55 | n/m | — | — | $3M |
| CODXCo-Diagnostics, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$6.0M | n/m | −$1.01 | n/m | — | — | $1M |
| AMIXAutonomix Medical, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$3.0M | n/m | −$2.51 | n/m | — | — | $586,766 |
| ROIVRoivant Sciences Ltd. | Healthcare | Nov 9 | Sep '26 | $35.1M | +1,650% | — | n/m | −$0.27 | n/m | -763.2% | — | $28.0B |
| TECHBio-Techne Corp | Healthcare | Nov 9 | Sep '26 | $300M | +4.5% | $28.0M | −26.3% | $0.18 | −25.0% | 12.2% | −4.4 pp | $11.4B |
| TGTXTG Therapeutics, Inc. | Healthcare | Nov 9 | Sep '26 | $260M | +60.5% | $55.0M | −85.9% | $0.35 | −85.6% | 33.0% | +14.9 pp | $9.5B |
| PRAXPraxis Precision Medicines, Inc. | Healthcare | Nov 9 | Sep '26 | $0.0M | n/m | −$94.0M | n/m | −$3.23 | n/m | — | — | $8.5B |
| IMVTImmunovant, Inc. | Healthcare | Nov 9 | Sep '26 | $0.0M | n/m | −$97.0M | n/m | −$0.47 | n/m | — | — | $6.9B |
| IBRXImmunityBio, Inc. | Healthcare | Nov 9 | Sep '26 | $49.0M | +53.1% | −$185M | n/m | −$0.18 | n/m | -159.7% | +13.8 pp | $6.7B |
| ORKAOruka Therapeutics, Inc. | Healthcare | Nov 9 | Sep '26 | $0.0M | n/m | −$50.0M | n/m | −$0.63 | n/m | — | — | $6.5B |
| IONSIonis Pharmaceuticals, Inc. | Healthcare | Nov 9 | Sep '26 | $243M | +54.8% | −$110M | n/m | −$0.66 | n/m | -53.9% | +48.4 pp | $4.5B |
| DFTXDefinium Therapeutics, Inc. | Healthcare | Nov 9 | Sep '26 | $0.0M | n/m | −$51.0M | n/m | −$0.37 | n/m | — | — | $4.0B |
| HIMSHims & Hers Health, Inc. | Healthcare | Nov 9 | Sep '26 | $890M | +48.6% | −$33.0M | −306.2% | −$0.14 | −333.3% | -7.4% | −9.4 pp | $4.0B |
| XENEXenon Pharmaceuticals Inc. | Healthcare | Nov 9 | Sep '26 | $0.0M | n/m | −$110M | n/m | −$1.11 | n/m | — | — | $3.8B |
| TNGXTango Therapeutics, Inc. | Healthcare | Nov 9 | Sep '26 | $0.0M | −100.0% | −$68.0M | −525.0% | −$0.39 | −378.6% | — | — | $3.7B |
| ABCLAbCellera Biologics Inc. | Healthcare | Nov 9 | Sep '26 | $11.0M | +22.2% | −$41.0M | n/m | −$0.13 | n/m | -501.1% | +350.7 pp | $3.6B |
| SGRYSurgery Partners, Inc. | Healthcare | Nov 9 | Sep '26 | $815M | −0.9% | −$21.0M | n/m | −$0.16 | n/m | 10.5% | −2.4 pp | $3.5B |
| MBXMBX Biosciences, Inc. | Healthcare | Nov 9 | Sep '26 | $0.0M | n/m | −$62.0M | n/m | −$1.29 | n/m | — | — | $2.6B |
| IMNMImmunome, Inc. | Healthcare | Nov 9 | Sep '26 | $0.0M | n/m | −$86.0M | n/m | −$0.76 | n/m | — | — | $2.0B |
| TRVITrevi Therapeutics, Inc. | Healthcare | Nov 9 | Sep '26 | $0.0M | n/m | −$21.0M | n/m | −$0.13 | n/m | — | — | $1.9B |
| SEPNSepterna, Inc. | Healthcare | Nov 9 | Sep '26 | $19.0M | −9.5% | −$27.0M | −437.5% | −$0.57 | −416.7% | -144.2% | −156.4 pp | $1.9B |
| ZYMEZymeworks Inc. | Healthcare | Nov 9 | Sep '26 | $256M | +814.3% | $174M | n/m | $2.28 | n/m | 69.3% | +149.3 pp | $1.8B |
| MAZEMaze Therapeutics, Inc. | Healthcare | Nov 9 | Sep '26 | $0.0M | n/m | −$48.0M | n/m | −$0.79 | n/m | — | — | $1.8B |
| WGSGeneDx Holdings Corp. | Healthcare | Nov 9 | Sep '26 | $123M | +5.1% | −$12.0M | n/m | −$0.41 | n/m | -8.5% | −5.7 pp | $1.4B |
| OCULOcular Therapeutix, Inc. | Healthcare | Nov 9 | Sep '26 | $13.0M | −13.3% | −$95.0M | n/m | −$0.42 | n/m | -760.1% | −287.8 pp | $1.3B |
| HROWHarrow, Inc. | Healthcare | Nov 9 | Sep '26 | $99.0M | +37.5% | $10.0M | +900.0% | $0.25 | +733.3% | 11.6% | −9.0 pp | $1.1B |
| SVRASavara, Inc. | Healthcare | Nov 9 | Sep '26 | $0.0M | n/m | −$43.0M | n/m | −$0.17 | n/m | — | — | $988M |
| MLABMesa Laboratories, Inc. | Healthcare | Nov 9 | Sep '26 | $62.0M | +1.6% | $4.0M | +100.0% | $0.75 | +66.7% | 13.5% | +5.7 pp | $757M |
| AURAAura Biosciences, Inc. | Healthcare | Nov 9 | Sep '26 | $0.0M | n/m | −$32.0M | n/m | −$0.29 | n/m | — | — | $744M |
| ATTOAttovia Therapeutics, Inc. | Healthcare | Nov 9 | Sep '26pending | $0.5M† | — | — | — | — | — | — | — | $679M |
| DCTHDelcath Systems, Inc. | Healthcare | Nov 9 | Sep '26 | $35.0M | +66.7% | $7.0M | +600.0% | $0.17 | +750.0% | 20.3% | +22.2 pp | $674M |
| BCAXBicara Therapeutics Inc. | Healthcare | Nov 9 | Sep '26 | $0.0M | n/m | −$71.0M | n/m | −$1.04 | n/m | — | — | $637M |
| GMRSGMR Solutions Inc. | Healthcare | Nov 9 | Sep '26 | $1.60B | — | $136M | — | $0.56 | — | 16.4% | — | $605M |
| ANNXAnnexon, Inc. | Healthcare | Nov 9 | Sep '26 | $0.0M | n/m | −$51.0M | n/m | −$0.25 | n/m | — | — | $569M |
| SENSSenseonics Holdings, Inc. | Healthcare | Nov 9 | Sep '26 | $20.0M | +150.0% | −$33.0M | n/m | −$0.50 | n/m | -162.8% | +79.3 pp | $557M |
| AVBPArriVent BioPharma, Inc. | Healthcare | Nov 9 | Sep '26 | $5.0M | n/m | −$40.0M | n/m | −$0.81 | n/m | 0.0% | — | $553M |
- Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
- YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
- pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.